Six weeks in, 65% of MC4R‑deficient patients lose at least 10% of body weight—yet semaglutide falls short. Discover the genetic hurdle and the next‑gen drugs reshaping obesity care.
miriam096
Posted on • Originally published at glpfacts.online
Why MC4R Trials Keep Flopping Without Semaglutide Fix
For further actions, you may consider blocking this person and/or reporting abuse
Top comments (0)